Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
CC transcript
Appointed director
Covidien plc (COV) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/03/2015 8-K Quarterly results
01/26/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/26/2015 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
Docs: "Ninth Supplemental Indenture, by and among Medtronic plc, Medtronic Global Holdings S.C.A., Covidien public limited company, Covidien International Finance S.A., Covidien Ltd. and Deutsche Bank Trust Company Americas, as trustee",
"DUBLIN, Ireland"
01/22/2015 8-K Quarterly results
Docs: "Covidien Reports First-Quarter 2015 Results • First-quarter net sales up 2% • First-quarter diluted GAAP earnings per share were $1.12; excluding specified items, adjusted diluted earnings per share were $1.11"
01/12/2015 8-K Other Events
01/06/2015 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "THIS ANNOUNCEMENT IS BEING MADE SOLELY TO COMPLY WITH THE REQUIREMENTS OF THE IRISH TAKEOVER RULES. THE INFORMATION SET OUT HEREIN CONCERNING THE RESULTS OF COVIDIEN PLC'S SHAREHOLDER MEETINGS ON JANUARY 6, 2015 WILL ALSO BE SET OUT IN COVIDIEN PLC'S FORM 8-K TO BE FILED ON JANUARY 6, 2015"
12/23/2014 8-K Other Events
12/04/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Chinese Ministry of Commerce Clears Medtronic Acquisition of Covidien"
12/01/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "European Commission Clears Medtronic Acquisition of Covidien"
11/26/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Medtronic Acquisition of Covidien Receives U.S. FTC Clearance"
11/21/2014 8-K Regulation FD Disclosure
11/17/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015 MINNEAPOLIS AND DUBLIN - Nov. 17, 2014 - Medtronic, Inc. and Covidien plc announced that following a hearding today before the Irish High Court the companies have scheduled shareholder meetings for Tuesday, January 6, 2015, in connection with the pending acquisition of Covidien by Medtronic. Medtronic's special shareholder meeting will be held on January 6, 2015 at 8:00 a.m. local time at the Hyatt Regency, 1300 Nicollet Mall, Minneapolis, MN, 55403. This meeting is being held to seek shareholder approval of the plan of merger contained in the transaction agreement entered into in connection with the proposed acquisition and related matters. Medtronic shareholders of record as of 5:00 p.m. Eastern Time on November 18..."
11/12/2014 8-K Regulation FD Disclosure
11/05/2014 8-K Quarterly results
Docs: "Covidien Reports Fourth-Quarter and Fiscal 2014 Results • Fourth-quarter net sales up 7%; Medical Devices sales up 8% • Fourth-quarter diluted GAAP earnings per share were $1.13; excluding specified items, adjusted diluted earnings per share were $1.15 • Fiscal 2014 diluted GAAP earnings per share were $3.65; excluding specified items, adjusted diluted earnings per share were $4.15, up 12%"
10/29/2014 8-K Other Events
10/24/2014 8-K Material Impairments
09/23/2014 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Covidien Severance Plan for U.S. Officers and Executives, as amended and restated",
"Form of Terms and Conditions of Option Award, as amended",
"FY09 Grant U.S. Option Terms and Conditions, as amended",
"Founders' Grant Standard Option Terms and Conditions, as amended"
07/25/2014 8-K Quarterly results
Docs: "Covidien Reports Third-Quarter Fiscal 2014 Results • Net sales up 4%; Medical Devices sales up 5% • Third-quarter diluted GAAP earnings per share were $0.67; excluding specified items, adjusted diluted earnings per share were $1.04, up 14%"
07/22/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Covidien Announces Leadership Appointment"
07/11/2014 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits Interactive Data
Docs: "Consent of Deloitte & Touche LLP",
"Updated Part I, Item 1. Business, Part I, Item 2. Properties, Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, Part II, Item 8. Financial Statements and Supplementary Data from Covidien plc’s Annual Report on Form 10-K for the fiscal year ended September 27, 2013"
06/16/2014 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Transaction Agreement, by and among Covidien plc, Medtronic, Inc., Kalani I Limited, Makani II Limited, Aviation Acquisition Co., Inc. and Aviation Merger Sub, LLC",
"Appendix III to the Rule 2.5 Announcement, (Conditions Appendix)",
"Expenses Reimbursement Agreement, by and between Covidien plc and Medtronic, Inc",
"Rule 2.5 Announcement"
05/28/2014 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amended and Restated Five-Year Credit Agreement"
04/28/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/25/2014 8-K Quarterly results
Docs: "Covidien Reports Second-Quarter Fiscal 2014 Results • Net sales up 3% • Second-quarter diluted GAAP earnings per share were $0.97; excluding specified items, adjusted diluted earnings per share were $0.96"
03/25/2014 8-K Submission of Matters to a Vote of Security Holders
02/06/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/27/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Covidien Chief Financial Officer Charles Dockendorff to Retire at End of Year"
01/24/2014 8-K Quarterly results
Docs: "Covidien Reports First-Quarter Fiscal 2014 Results • Net sales up 3% ; Medical Devices sales up 3% • First-quarter diluted GAAP earnings per share were $0.87; excluding specified items, adjusted diluted earnings per share were $1.00"
12/16/2013 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Covidien Announces Reporting Changes and Revised Revenue Guidance DUBLIN, Ireland – December 16, 2013 - Covidien plc today provided further details regarding its previously disclosed realignment of reportable segments and announced additional changes in its revenue reporting format. These changes are designed to further align with the company’s recent reorganization and provide additional transparency of financial performance. The new format provides a worldwide view of sales across three major product categories while enhancing geographic reporting by breaking out non-U.S. sales into new categories for emerging and non-U.S. developed markets. The company will begin using this format when it releases its fiscal first quarter 2014 results in January. “Our new revenue reporting format more c...",
"Covidien Revised Financial Information"
12/09/2013 8-K Regulation FD Disclosure
Docs: "Covidien Announces Definitive Agreement to Acquire Given Imaging"
11/08/2013 8-K Form 8-K - Current report
09/12/2013 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Covidien Revised Financial Information"
08/01/2013 8-K Quarterly results
Docs: "Covidien Reports Third-Quarter Results • Net sales up 3% ; Medical Devices sales up 4% • Third-quarter diluted GAAP earnings per share from continuing operations were $0.85; excluding specified items, adjusted diluted earnings per share from continuing operations were $0.91"
05/10/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy